Team 團隊

姚文萱 博士  董事長

美國柏克萊加州大學生物物理學博士；國立台灣大學 物理系 學士 

道品股份有限公司董事長；中央研究院生醫所研究技師；工業技術研究院生醫資訊部經理

黃培瑛 博士  創辦人

美國柏克萊加州大學分子生物學博士；國立台灣大學 農化系 學士 

中研研究院 農生中心生物資訊核心實驗室負責人；國立台灣師範大學兼任助理教授；工業技術研究院生醫資訊部研究員；中研院統計所博士後研究員

李明哲 醫師 董事/醫學顧問

臺北醫學大學醫學系

中華民國器官捐贈學會理事長；花蓮慈濟醫院癌症醫學中心副主任；慈濟醫學大學專任教授

鄭敬楓 醫師  董事/醫學顧問

台北醫學大學醫學系

台北慈濟醫院副院長；中研院生醫所合聘研究員；花蓮慈濟醫院兒科部及研究部主任  

 

 

 

         

留言

發佈留言

此網誌的熱門文章

Products - OncoTeller®

圖片
OncoTeller® 整合茂英基因科技自行開發的多個基因標記，以全基因體微陣列作RNA定量，可達到一次檢測，多項解答 OncoTeller® 檢測程序  
閱讀更多

Selected validation data 驗證

圖片
MetaDx was applied to metastatic cancer to identify the tissue of origin. OncoDx was applied to lung cancer to distinguish malignant tissue from non-tumor. OncoDx was applied to kidney cancer subtyping. Ovarian cancer was discerned from benign tumor or adjacent normal by the gene marker developed at Mao Ying Genetech Inc. OncoDx also functioned with magnetic beads.
閱讀更多

最新動態 Events

圖片
News Patent no. I725248 was issued on Apr. 21, 2021. Mao Ying Participated the Healthcare Expo Taiwan and hosted a booth to introduce the product OncoTeller® to attendees in December of 2019.  Dr. Pei-Ing Hwang was invited to lecture at the symposium emphasizing biotech startups by female founders.  Participating the 2018 BIO International Convention, June 4-7, 2018, Boston, MA Mao Ying Genetech Inc. was elected by the Taipei Municipal Government as one of the five Taipei delegation biotech companies to attend the BIO International Convention of 2018 and hosted the booth #2701 in Boston. (2018-5-28) A company presentation was given by Dr. Pei-Ing Hwang, the founder of Mao Ying Genetech Inc. at the pre-meeting held at Harvard medical school.  An exclusive interview with the broadcaster.  Dr. Hwang, the General Manager of Mao Ying Genetech Inc., received an exclusive interview by the "needs RADIO" global broadcasting network. (2017-11-27) Mao Ying Genetech Inc. recei...
閱讀更多